ZFPM2-AS1

Across TCGA pan-cancer cohorts, ZFPM2-AS1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated ZFPM2-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ZFPM2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZFPM2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and DLBC show a favorable association.

KIRC, STAD, and UVM are the cancer types where ZFPM2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.525	0.673	<.001	124	view →
STAD	DFS	Median	II,III,IV	0.454	0.606	<.001	119	view →
UVM	DFS	Tertile	All	0.262	0.719	<.001	88	view →
LGG	DFS	Median	All	0.759	0.898	<.001	54	view →
LIHC	OS	Median	All	0.419	0.602	<.001	54	view →
LUAD	OS	Median	III,IV	0.349	0.625	.006	40	view →
MESO	OS	Median	II,III,IV	0.290	0.482	.008	26	view →
UCEC	DFS	Tertile	All	0.527	0.763	.002	24	view →
SARC	OS	Median	All	0.792	0.882	.005	16	view →
THCA	OS	Median	IV	0.599	1.000	.004	15	view →
ACC	OS	Quartile	All	0.795	1.000	.007	15	view →
SKCM	DFS	Median	IV	0.187	0.763	.006	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

ZFPM2-AS1–KIRC (DFS)

Open the KIRC breakdown →